AIMM Therapeutics B.V. - Product Pipeline Review - 2016

  • ID: 3635567
  • Company Profile
  • 41 pages
  • Global Markets Direct
1 of 4
AIMM Therapeutics B.V. - Product Pipeline Review - 2016

Summary

The report ‘AIMM Therapeutics B.V. - Product Pipeline Review - 2016’, provides an overview of the AIMM Therapeutics B.V.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by AIMM Therapeutics B.V., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of AIMM Therapeutics B.V.
- The report provides overview of AIMM Therapeutics B.V. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses AIMM Therapeutics B.V.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features AIMM Therapeutics B.V.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate AIMM Therapeutics B.V.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for AIMM Therapeutics B.V.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding AIMM Therapeutics B.V.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

AIMM Therapeutics B.V. Snapshot

AIMM Therapeutics B.V. Overview

Key Information

Key Facts

AIMM Therapeutics B.V. - Research and Development Overview

Key Therapeutic Areas

AIMM Therapeutics B.V. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

AIMM Therapeutics B.V. - Pipeline Products Glance

AIMM Therapeutics B.V. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

AIMM Therapeutics B.V. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

AIMM Therapeutics B.V. - Unknown Stage Pipeline Products

Unknown Products/Combination Treatment Modalities

AIMM Therapeutics B.V. - Drug Profiles

CR-8020

Product Description

Mechanism of Action

R&D Progress

Bispecific Monoclonal Antibody to Inhibit Hemagglutinin for Seasonal and Pandemic Influenza

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Acute Myelocytic Leukemia

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Colon Carcinoma

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Cytomegalovirus Infections

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Hepatitis C Infection

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Human Rhinovirus Infections

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Melanoma

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for MRSA Infections

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Multiple Myeloma

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Oncology

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Pancreatic Cancer

Product Description

Mechanism of Action

R&D Progress

AM-18

Product Description

Mechanism of Action

R&D Progress

AM-28

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Clostridium Difficile Infections

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies for Hepatitis B Infection

Product Description

Mechanism of Action

R&D Progress

AIMM Therapeutics B.V. - Pipeline Analysis

AIMM Therapeutics B.V. - Pipeline Products by Target

AIMM Therapeutics B.V. - Pipeline Products by Route of Administration

AIMM Therapeutics B.V. - Pipeline Products by Molecule Type

AIMM Therapeutics B.V. - Pipeline Products by Mechanism of Action

AIMM Therapeutics B.V. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

AIMM Therapeutics B.V., Key Information

AIMM Therapeutics B.V., Key Facts

AIMM Therapeutics B.V. - Pipeline by Indication, 2016

AIMM Therapeutics B.V. - Pipeline by Stage of Development, 2016

AIMM Therapeutics B.V. - Monotherapy Products in Pipeline, 2016

AIMM Therapeutics B.V. - Out-Licensed Products in Pipeline, 2016

AIMM Therapeutics B.V. - Out-Licensed Products/ Combination Treatment Modalities, 2016

AIMM Therapeutics B.V. - Phase II, 2016

AIMM Therapeutics B.V. - Preclinical, 2016

AIMM Therapeutics B.V. - Discovery, 2016

AIMM Therapeutics B.V. - Unknown, 2016

AIMM Therapeutics B.V. - Pipeline by Target, 2016

AIMM Therapeutics B.V. - Pipeline by Route of Administration, 2016

AIMM Therapeutics B.V. - Pipeline by Molecule Type, 2016

AIMM Therapeutics B.V. - Pipeline Products by Mechanism of Action, 2016

List of Figures

AIMM Therapeutics B.V. - Pipeline by Top 10 Indication, 2016

AIMM Therapeutics B.V. - Pipeline by Stage of Development, 2016

AIMM Therapeutics B.V. - Monotherapy Products in Pipeline, 2016

AIMM Therapeutics B.V. - Pipeline by Target, 2016

AIMM Therapeutics B.V. - Pipeline by Route of Administration, 2016

AIMM Therapeutics B.V. - Pipeline by Molecule Type, 2016

AIMM Therapeutics B.V. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll